Stay up-to-date with our latest news, blog articles, videos, and event announcements. Learn from business success stories and gain access to valuable e-books and resources.
In the high-stakes world of small-molecule development, the transition from pre-clinical “garage-style” synthesis to a scalable, GMP-ready clinical candidate is where most asset valuations either soar or plummet. For small and mid-sized pharma companies, this is not just a technical hurdle, it is a […]
It has been three years since our Kawagoe site became part of the Adragos family, and it is a milestone that fills me and our entire team with immense pride. This journey has been one of transformation, growth, and partnership. […]
Adragos Pharma is pleased to announce its participation in DCAT Week 2026, taking place in New York City from March 23-26th. As a global Contract Development and Manufacturing Organization (CDMO), we look forward to engaging with industry leaders, partners, and […]
In the highly regulated world of pharmaceutical manufacturing, the production of controlled substances represents a pinnacle of complexity. The process demands that requirements for quality, safety, operability, regulatory compliance, and security are all satisfied simultaneously. This unyielding standard necessitates an […]
In the high-stakes world of aseptic manufacturing, the distance between a successful batch and a multi-million-euro “atypical finding” is often measured in millimeters—the diameter of a tubing line, the viscosity of a bulk solution, or the precise pressure of a […]
Courroux, Switzerland – Wednesday, 21 January, 2026 Adragos Pharma, a leader in the CDMO industry, is pleased to announce it has received formal approval from the Swiss Agency for Therapeutic Products (Swissmedic) for their newly modernized sterile manufacturing suite, the […]
Get notified on our latest news.
